These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
1011 related articles for article (PubMed ID: 12859672)
41. C-Abl tyrosine kinase signaling: a new player in AD tau pathology. Estrada LD; Zanlungo SM; Alvarez AR Curr Alzheimer Res; 2011 Sep; 8(6):643-51. PubMed ID: 21605041 [TBL] [Abstract][Full Text] [Related]
42. Accelerated amyloid deposition, neurofibrillary degeneration and neuronal loss in double mutant APP/tau transgenic mice. Ribé EM; Pérez M; Puig B; Gich I; Lim F; Cuadrado M; Sesma T; Catena S; Sánchez B; Nieto M; Gómez-Ramos P; Morán MA; Cabodevilla F; Samaranch L; Ortiz L; Pérez A; Ferrer I; Avila J; Gómez-Isla T Neurobiol Dis; 2005 Dec; 20(3):814-22. PubMed ID: 16125396 [TBL] [Abstract][Full Text] [Related]
43. Discoveries of tau, abnormally hyperphosphorylated tau and others of neurofibrillary degeneration: a personal historical perspective. Iqbal K; Grundke-Iqbal I J Alzheimers Dis; 2006; 9(3 Suppl):219-42. PubMed ID: 16914861 [TBL] [Abstract][Full Text] [Related]
44. A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics. Rosenmann H; Grigoriadis N; Eldar-Levy H; Avital A; Rozenstein L; Touloumi O; Behar L; Ben-Hur T; Avraham Y; Berry E; Segal M; Ginzburg I; Abramsky O Exp Neurol; 2008 Jul; 212(1):71-84. PubMed ID: 18490011 [TBL] [Abstract][Full Text] [Related]
45. Mechanisms of tau self-aggregation and neurotoxicity. Farías G; Cornejo A; Jiménez J; Guzmán L; Maccioni RB Curr Alzheimer Res; 2011 Sep; 8(6):608-14. PubMed ID: 21605046 [TBL] [Abstract][Full Text] [Related]
46. Pre-assembled tau filaments phosphorylated by GSK-3b form large tangle-like structures. Rankin CA; Sun Q; Gamblin TC Neurobiol Dis; 2008 Sep; 31(3):368-77. PubMed ID: 18588978 [TBL] [Abstract][Full Text] [Related]
47. Enhanced Tau Aggregation in the Presence of Amyloid β. Bennett RE; DeVos SL; Dujardin S; Corjuc B; Gor R; Gonzalez J; Roe AD; Frosch MP; Pitstick R; Carlson GA; Hyman BT Am J Pathol; 2017 Jul; 187(7):1601-1612. PubMed ID: 28500862 [TBL] [Abstract][Full Text] [Related]
48. Specific tau phosphorylation sites correlate with severity of neuronal cytopathology in Alzheimer's disease. Augustinack JC; Schneider A; Mandelkow EM; Hyman BT Acta Neuropathol; 2002 Jan; 103(1):26-35. PubMed ID: 11837744 [TBL] [Abstract][Full Text] [Related]
49. Staging of neurofibrillary degeneration caused by human tau overexpression in a unique cellular model of human tauopathy. Hall GF; Lee VM; Lee G; Yao J Am J Pathol; 2001 Jan; 158(1):235-46. PubMed ID: 11141497 [TBL] [Abstract][Full Text] [Related]
50. Tau pathology in Alzheimer disease and other tauopathies. Iqbal K; Alonso Adel C; Chen S; Chohan MO; El-Akkad E; Gong CX; Khatoon S; Li B; Liu F; Rahman A; Tanimukai H; Grundke-Iqbal I Biochim Biophys Acta; 2005 Jan; 1739(2-3):198-210. PubMed ID: 15615638 [TBL] [Abstract][Full Text] [Related]
51. Phosphorylation that detaches tau protein from microtubules (Ser262, Ser214) also protects it against aggregation into Alzheimer paired helical filaments. Schneider A; Biernat J; von Bergen M; Mandelkow E; Mandelkow EM Biochemistry; 1999 Mar; 38(12):3549-58. PubMed ID: 10090741 [TBL] [Abstract][Full Text] [Related]
52. Caspase cleavage of tau: linking amyloid and neurofibrillary tangles in Alzheimer's disease. Gamblin TC; Chen F; Zambrano A; Abraha A; Lagalwar S; Guillozet AL; Lu M; Fu Y; Garcia-Sierra F; LaPointe N; Miller R; Berry RW; Binder LI; Cryns VL Proc Natl Acad Sci U S A; 2003 Aug; 100(17):10032-7. PubMed ID: 12888622 [TBL] [Abstract][Full Text] [Related]
53. The relationship between amyloid and tau. Hardy J J Mol Neurosci; 2003 Apr; 20(2):203-6. PubMed ID: 12794314 [TBL] [Abstract][Full Text] [Related]
54. Phosphorylation of Tau at S422 is enhanced by Abeta in TauPS2APP triple transgenic mice. Grueninger F; Bohrmann B; Czech C; Ballard TM; Frey JR; Weidensteiner C; von Kienlin M; Ozmen L Neurobiol Dis; 2010 Feb; 37(2):294-306. PubMed ID: 19781645 [TBL] [Abstract][Full Text] [Related]
56. Alzheimer's disease. A new take on tau. Marx J Science; 2007 Jun; 316(5830):1416-7. PubMed ID: 17556561 [No Abstract] [Full Text] [Related]
57. [Significance of tau in the development of Alzheimer's disease]. Takashima A Brain Nerve; 2010 Jul; 62(7):701-8. PubMed ID: 20675874 [TBL] [Abstract][Full Text] [Related]
58. Minimalistic in vitro systems for investigating tau pathology. Hallinan GI; Pitera AP; Patel P; West J; Deinhardt K J Neurosci Methods; 2019 May; 319():69-76. PubMed ID: 30278185 [TBL] [Abstract][Full Text] [Related]
59. GFP-Mutant Human Tau Transgenic Mice Develop Tauopathy Following CNS Injections of Alzheimer's Brain-Derived Pathological Tau or Synthetic Mutant Human Tau Fibrils. Gibbons GS; Banks RA; Kim B; Xu H; Changolkar L; Leight SN; Riddle DM; Li C; Gathagan RJ; Brown HJ; Zhang B; Trojanowski JQ; Lee VM J Neurosci; 2017 Nov; 37(47):11485-11494. PubMed ID: 28986461 [TBL] [Abstract][Full Text] [Related]
60. Endogenous Murine Amyloid-β Peptide Assembles into Aggregates in the Aged C57BL/6J Mouse Suggesting These Animals as a Model to Study Pathogenesis of Amyloid-β Plaque Formation. Ahlemeyer B; Halupczok S; Rodenberg-Frank E; Valerius KP; Baumgart-Vogt E J Alzheimers Dis; 2018; 61(4):1425-1450. PubMed ID: 29376876 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]